Employees Retirement System of Texas bought a new stake in Danaher Co. (NYSE:DHR – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 240,300 shares of the conglomerate’s stock, valued at approximately $55,161,000.
Several other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in Danaher by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate’s stock valued at $13,715,641,000 after acquiring an additional 315,912 shares during the period. Geode Capital Management LLC raised its position in shares of Danaher by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate’s stock valued at $3,056,996,000 after purchasing an additional 315,446 shares during the period. Norges Bank purchased a new stake in shares of Danaher during the 4th quarter valued at approximately $2,130,740,000. Bank of New York Mellon Corp boosted its holdings in Danaher by 5.4% in the 4th quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock worth $1,971,609,000 after buying an additional 441,012 shares during the period. Finally, Fisher Asset Management LLC boosted its holdings in Danaher by 0.6% in the 4th quarter. Fisher Asset Management LLC now owns 4,578,945 shares of the conglomerate’s stock worth $1,051,097,000 after buying an additional 26,305 shares during the period. 79.05% of the stock is currently owned by institutional investors.
Insider Activity
In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 11.10% of the company’s stock.
Analyst Ratings Changes
Danaher Stock Down 8.3 %
Shares of NYSE:DHR opened at $181.42 on Monday. Danaher Co. has a 12-month low of $165.17 and a 12-month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock’s 50-day moving average price is $209.99 and its 200-day moving average price is $233.73. The stock has a market capitalization of $129.66 billion, a P/E ratio of 34.36, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the company posted $2.09 EPS. On average, equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.32 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.71%. Danaher’s payout ratio is presently 24.24%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- 10 Best Airline Stocks to Buy
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Disney 2025 Shareholders: Major Updates for Investors
- How to Invest in the Best Canadian Stocks
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.